Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Journal of Oncology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.26.4.863PMID 15753979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell death: critical control points.

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004cited by this paper
• 5-Aza-2′-deoxycytidine Activates the p53/p21Waf1/Cip1 Pathway to Inhibit Cell Proliferation*

  2004cited by this paper
• Evaluation of antineoplastic action of 5-aza-2′-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines

  2004cited by this paper
• The absence of p53 is critical for the induction of apoptosis by 5-aza-2′-deoxycytidine

  2004cited by this paper
• Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells

  2004cited by this paper
• Molecular biology of prostate cancer

  2004cited by this paper
• Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

  2003cited by this paper
• Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed‐backbone antisense oligonucleotides: In vitro and in vivo activities and mechanisms

  2003cited by this paper
• Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity.

  2003cited by this paper
• p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage.

  2003cited by this paper
• Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis.

  2003cited by this paper
• Apoptosis - the p53 network

  2003cited by this paper
• 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

  2002cited by this paper
• Reactivating the expression of methylation silenced genes in human cancer

  2002cited by this paper
• Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells

  2002cited by this paper
• DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

  2002cited by this paper
• 5-Aza-2'-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation.

  2001cited by this paper
• Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells

  2001cited by this paper
• Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

  2001cited by this paper
• Defects of DNA mismatch repair in human prostate cancer.

  2001cited by this paper
• Four deaths and a funeral: from caspases to alternative mechanisms

  2001cited by this paper
• DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.

  2001cited by this paper
• Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.

  2000cited by this paper
• p53: death star.

  2000cited by this paper
• Noncaspase proteases in apoptosis

  2000cited by this paper
• Methylation and expression of amplified esterase genes in the aphid Myzus persicae (Sulzer).

  2000cited by this paper
• Chronic myelogenous leukemia in nonlymphoid blastic phase

  1999cited by this paper
• Apoptosis and therapy

  1999cited by this paper
• Molecular alterations in the TP53 gene of peripheral blood cells of patients with chronic myeloid leukemia

  1998cited by this paper
• Detection of p53 gene mutations in human leukemia by PCR-SSCP analysis and direct nucleotide sequencing.

  1998cited by this paper
• A Phase II Study of 5-AZA-2'Deoxycytidine (Decitabine) in Hormone Independent Metastatic (D2) Prostate Cancer

  1998cited by this paper
• Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer.

  1997cited by this paper
• Pharmacological approach for optimization of the dose schedule of 5-Aza-2’-deoxycytidine (Decitabine) for the therapy of leukemia

  1997cited by this paper
• Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.

  1994cited by this paper

• KiSS-1 Modulation by Epigenetic Agents Improves the Cisplatin Sensitivity of Lung Cancer Cells

  2024cites this paper
• Predicting potential small molecule-miRNA associations utilizing truncated schatten p-norm

  2023cites this paper
• Effect of Zebularine on Apoptotic Pathways in Hepatocellular Carcinoma Cell Lines

  2023cites this paper
• Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer

  2022cites this paper
• The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells

  2021cites this paper
• Endogenous Retroviral–K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell Carcinoma

  2021cites this paper
• 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer

  2018cites this paper
• Decitabine attenuates nociceptive behavior in a murine model of bone cancer pain

  2018cites this paper
• Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression

  2017cites this paper
• Conditioning neoadjuvant therapies for improved immunotherapy of cancer.

  2017cites this paper
• PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas

  2015cites this paper
• Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.

  2015cites this paper
• Immunotherapy of Cancer: Reprogramming Tumor/Immune Cellular Crosstalk to Improve Anti-Tumor Efficacy

  2015cites this paper
• PHF21Bas a candidate tumor suppressor gene in head and neck squamous cell carcinomas

  2015cites this paper
• Pathways related to PMA-differentiated THP1 human monocytic leukemia cells revealed by RNA-Seq

  2015cites this paper
• Low concentrations of 5-aza-2′-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression

  2015cites this paper
• Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2'-deoxycytidine.

  2014cites this paper
• Activation of the intrinsic apoptosis pathway contributes to the induction of apoptosis in hepatocellular carcinoma cells by valproic acid

  2014cites this paper
• Combination Effect of Epigenetic Regulation and Ionizing Radiation in Colorectal Cancer Cells

  2014cites this paper
• MicroRNA-302 induces proliferation and inhibits oxidant-induced cell death in human adipose tissue-derived mesenchymal stem cells

  2014cites this paper
• Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.

  2014cites this paper
• Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.

  2013cites this paper
• Manipulating the epigenome for the treatment of urological malignancies.

  2013cites this paper
• Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk

  2012cites this paper
• Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation.

  2012cites this paper
• The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria‐mediated apoptosis and DNA damage in p53 mutant leukemic T cells

  2012cites this paper
• Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-κB inhibitor, in human prostate cancer androgen-independent cell lines.

  2011cites this paper
• Changes in the levels of DNA methylation in testis and liver of SD rats neonatally exposed to 5‐aza‐2′‐deoxycytidine and cadmium

  2011cites this paper
• Functional analysis of the histone methyltransferase SET9 in androgen receptor regulation and prostate cancer

  2011cites this paper
• Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes

  2011cites this paper
• GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells

  2011influential citation
• Hypomethylating agents for urologic cancers.

  2011cites this paper
• The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells

  2011cites this paper
• Irradiation, Cisplatin, and 5-Azacytidine Upregulate Cytomegalovirus Promoter in Tumors and Muscles: Implementation of Non-invasive Fluorescence Imaging

  2010cites this paper
• 5‐azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors

  2010cites this paper
• Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.

  2010cites this paper
• DNA demethylation and histone deacetylation inhibition act synergistically to re-express oestrogen receptor beta and induce ap

  2010cites this paper
• The role of epigenetic modifications in prostate tumourigenesis.

  2010cites this paper
• Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.

  2009cites this paper
• DNA methyltransferase inhibitor 5‐aza‐CdR enhances the radiosensitivity of gastric cancer cells

  2009cites this paper
• Study of 5-Aza-CdR on Transcription Regulation of RASSF1A Gene in the BIU87 Cell Line

  2009cites this paper
• Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1

  2009cites this paper
• Small Interfering RNA–Directed Knockdown of Uracil DNA Glycosylase Induces Apoptosis and Sensitizes Human Prostate Cancer Cells to Genotoxic Stress

  2009cites this paper
• DNA demethylation and histone deacetylation inhibition co‐operate to re‐express estrogen receptor beta and induce apoptosis in prostate cancer cell‐lines

  2008cites this paper
• Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylation.

  2008cites this paper
• Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.

  2008cites this paper
• Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation.

  2007cites this paper
• Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.

  2007cites this paper
• Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications

  2007cites this paper
• The DU145 human prostate carcinoma cell line harbors a temperature‐sensitive allele of p53

  2006cites this paper
• In search of p53 target genes for the therapeutic manipulation of cancer.

  2006cites this paper
• Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer

  2005cites this paper
• Aus der Klinik für Urologie

  2005cites this paper